GH1 and cancer: The same conclusion was obtained in a study of 58,603 patients from the Pfizer International Growth Database, in which no association was found between GH treatment and an increase in the incidence of cancer [50], nor was an association found in a cohort of 6840 GH-treated adult hypopituitary patients [51].